BCL2 and breast cancer: We found that GalCer specifically downregulated the expression of TNFRSF1B and TNFRSF9 genes and increased BCL2 gene expression at the mRNA and protein levels, proving that changes in their expression directly affect the apoptotic properties of BC cells.